These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7901234)

  • 1. Vasoactive intestinal peptide inhibits interleukin (IL)-2 and IL-4 production through different molecular mechanisms in T cells activated via the T cell receptor/CD3 complex.
    Sun L; Ganea D
    J Neuroimmunol; 1993 Oct; 48(1):59-69. PubMed ID: 7901234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasoactive intestinal peptide downregulates the expression of IL-2 but not of IFN gamma from stimulated murine T lymphocytes.
    Ganea D; Sun L
    J Neuroimmunol; 1993 Sep; 47(2):147-58. PubMed ID: 8103776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasoactive intestinal peptide inhibits interleukin (IL)-2 and IL-4 production in murine thymocytes activated via the TCR/CD3 complex.
    Xin Z; Tang H; Ganea D
    J Neuroimmunol; 1994 Oct; 54(1-2):59-68. PubMed ID: 7929804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide-38 inhibit IL-10 production in murine T lymphocytes.
    Martinez C; Delgado M; Gomariz RP; Ganea D
    J Immunol; 1996 Jun; 156(11):4128-36. PubMed ID: 8666779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasoactive intestinal peptide inhibits IL-4 production in murine T cells by a post-transcriptional mechanism.
    Wang HY; Xin Z; Tang H; Ganea D
    J Immunol; 1996 May; 156(9):3243-53. PubMed ID: 8617946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of vasoactive intestinal peptide (VIP) on cytokine production and expression of VIP receptors in thymocyte subsets.
    Xin Z; Jiang X; Wang HY; Denny TN; Dittel BN; Ganea D
    Regul Pept; 1997 Sep; 72(1):41-54. PubMed ID: 9404731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasoactive intestinal peptide inhibits cytokine production in T lymphocytes through cAMP-dependent and cAMP-independent mechanisms.
    Wang HY; Jiang X; Gozes I; Fridkin M; Brenneman DE; Ganea D
    Regul Pept; 1999 Oct; 84(1-3):55-67. PubMed ID: 10535409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of calcitonin gene-related peptide and vasoactive intestinal peptide on murine CD4 and CD8 T cell proliferation.
    Teresi S; Boudard F; Bastide M
    Immunol Lett; 1996 Apr; 50(1-2):105-13. PubMed ID: 8793567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin 4 suppresses interleukin 2 and interferon gamma production by naive T cells stimulated by accessory cell-dependent receptor engagement.
    Tanaka T; Hu-Li J; Seder RA; Fazekas de St Groth B; Paul WE
    Proc Natl Acad Sci U S A; 1993 Jul; 90(13):5914-8. PubMed ID: 8100998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of T lymphocyte proliferation in mice infected with Schistosoma mansoni: VIP suppresses mitogen- and antigen-induced T cell proliferation possibly by inhibiting IL-2 production.
    Metwali A; Blum A; Mathew R; Sandor M; Lynch RG; Weinstock JV
    Cell Immunol; 1993 Jun; 149(1):11-23. PubMed ID: 8099848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective effects of vasoactive intestinal peptide on the mitogenic response of murine T cells.
    Ottaway CA
    Immunology; 1987 Oct; 62(2):291-7. PubMed ID: 2960611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of mouse T-cell proliferation by CGRP and VIP: effects of these neuropeptides on IL-2 production and cAMP synthesis.
    Boudard F; Bastide M
    J Neurosci Res; 1991 May; 29(1):29-41. PubMed ID: 1653367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of cytokine expression in murine lymphocytes by PACAP and VIP.
    Tang H; Sun L; Xin Z; Ganea D
    Ann N Y Acad Sci; 1996 Dec; 805():768-78. PubMed ID: 8993475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit expression of Fas ligand in activated T lymphocytes by regulating c-Myc, NF-kappa B, NF-AT, and early growth factors 2/3.
    Delgado M; Ganea D
    J Immunol; 2001 Jan; 166(2):1028-40. PubMed ID: 11145682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VIP1 and VIP2 receptors but not PVR1 mediate the effect of VIP/PACAP on cytokine production in T lymphocytes.
    Jiang X; Wang HY; Yu J; Ganea D
    Ann N Y Acad Sci; 1998 Dec; 865():397-407. PubMed ID: 9928038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasoactive intestinal peptide induces cell cycle arrest and regulatory functions in human T cells at multiple levels.
    Anderson P; Gonzalez-Rey E
    Mol Cell Biol; 2010 May; 30(10):2537-51. PubMed ID: 20231362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of IL-2 production in murine lymphocytes by substance P and related tachykinins.
    Rameshwar P; Gascon P; Ganea D
    J Immunol; 1993 Sep; 151(5):2484-96. PubMed ID: 7689609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation.
    de Waal Malefyt R; Yssel H; de Vries JE
    J Immunol; 1993 Jun; 150(11):4754-65. PubMed ID: 7684412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasoactive intestinal peptide stimulates T lymphocytes to release IL-5 in murine schistosomiasis mansoni infection.
    Mathew RC; Cook GA; Blum AM; Metwali A; Felman R; Weinstock JV
    J Immunol; 1992 Jun; 148(11):3572-7. PubMed ID: 1588046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasoactive intestinal peptide modulates Langerhans cell immune function.
    Kodali S; Ding W; Huang J; Seiffert K; Wagner JA; Granstein RD
    J Immunol; 2004 Nov; 173(10):6082-8. PubMed ID: 15528344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.